Knowledge (XXG)

COVID-19 vaccination in Equatorial Guinea

Source 📝

Plan to immunize against COVID-19

COVID-19 vaccination in Equatorial Guinea
DateFebruary 15, 2021 (2021-02-15) – present
LocationEquatorial Guinea
CauseCOVID-19 pandemic
Participants293,702 total doses administered

COVID-19 vaccination in Equatorial Guinea is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

Equatorial Guinea began its vaccination program on 15 February 2021, initially with 100,000 doses of the Sinopharm BIBP vaccine donated by China.

Background

History

Timeline

February 2021

On 11 February 2021, 100,000 donated doses of the Sinopharm BIBP vaccine arrived in Equatorial Guinea from China.

March 2021

By the end of the month 9,265 doses had been administered.

April 2021

By the end of the month 55,799 doses had been administered. 8,389 persons had been fully vaccinated.

May 2021

By the end of the month 219,677 doses had been administered. 71,598 persons had been fully vaccinated.

June 2021

On 16 June 2021, Equatorial Guinea buys 500,000 doses of the Sinopharm BIBP vaccine. By the end of the month 260,528 doses had been administered. 111,343 persons had been fully vaccinated.

July 2021

By the end of the month 301,413 doses had been administered. 122,500 persons had been fully vaccinated.

August 2021

By the end of the month 331,807 doses had been administered. 141,326 persons had been fully vaccinated.

September 2021

By the end of the month 397,083 doses had been administered. 167,635 persons had been fully vaccinated.

October 2021

By the end of the month 426,780 doses had been administered. 186,670 persons (32% of the target population) had been fully vaccinated.

November 2021

By the end of the month 443,135 doses had been administered. 196,616 persons (34% of the target population) had been fully vaccinated.

December 2021

By the end of the month 452,572 doses had been administered. 203,357 persons (35% of the target population) had been fully vaccinated.

February 2022

By the end of the month 463,549 doses had been administered. 206,023 persons had been fully vaccinated.

March 2022

By the end of the month 473,409 doses had been administered. 210,706 persons had been fully vaccinated.

April 2022

By the end of the month 479,991 doses had been administered. 214,486 persons had been fully vaccinated.

Progress

Cumulative vaccinations in Equatorial Guinea

References

  1. "owid/covid-19-data". GitHub. Archived from the original on 22 June 2021. Retrieved 12 July 2021.
  2. "Equatorial Guinea: WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data". covid19.who.int. Archived from the original on 16 April 2020. Retrieved 12 July 2021.
  3. "Equatorial Guinea buys 500,000 Sinopharm COVID-19 vaccines". Reuters. 16 June 2021. Archived from the original on 13 July 2021. Retrieved 12 July 2021.
  4. "China donates 100,000 Covid vaccines to Equatorial Guinea". France24. 11 February 2021. Archived from the original on 21 July 2021. Retrieved 21 July 2021.
  5. "Equatorial Guinea buys 500,000 Sinopharm COVID-19 vaccines". Reuters. 16 June 2021. Archived from the original on 13 July 2021. Retrieved 22 July 2021.
  6. "COVID-19 Vaccine Statistics: As of July 17, 2021". covidvax.live. Archived from the original on 21 July 2021. Retrieved 21 July 2021.
Pre-pandemic
2020
2021
2022
2023 and after
Africa
Northern
Eastern
Southern
Central
Western
Asia
Central/North
East
Mainland China
South
India
By location
Southeast
Malaysia
Philippines
West
Europe
United Kingdom
By location
Eastern
Western Balkans
European Union
EFTA countries
Microstates
North
America
Atlantic
Canada
Caribbean
Countries
British Overseas Territories
Caribbean Netherlands
French West Indies
US insular areas
Central America
United States
responses
By location
Oceania
Australia
New Zealand
South
America
Others
Culture and
entertainment
Arts and
cultural heritage
Education
By country
Sports
By country
By sport
Society
and rights
Social impact
Labor
Human rights
Legal
Minority
Religion
Economic
By country
By industry
Supply and trade
Financial markets
Information
Misinformation
Politics
Political impact
Protests
International relations
Language
Others
Health issues
Medical topics
Testing and
epidemiology
Apps
Prevention
Vaccines
Topics
Authorized
DNA
Inactivated
mRNA
Subunit
Viral vector
Virus-like particles
In trials
Attenuated
DNA
Inactivated
RNA
Subunit
Viral vector
Virus-like particles
Deployment
by location
Africa
Asia
Europe
North America
Oceania
South America
Others
Treatment
Monoclonal antibodies
Small molecule antivirals
Specific
General
Institutions
Hospitals and
medical clinics
Mainland China
Others
Organizations
Global
By location
Health
institutes
Pandemic
institutes
Relief funds
People
Medical
professionals
Researchers
Officials
WHO
By location
Others
Deaths
Data (templates)
Global
Africa
Americas
Asia
Europe
Oceania
Others
Sovereign states
States with limited
recognition
Dependencies and
other territories


Stub icon

This article about COVID-19 vaccines is a stub. You can help Knowledge (XXG) by expanding it.

Stub icon

This Cameroon-related article is a stub. You can help Knowledge (XXG) by expanding it.

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.